bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2011.
Asia
Europe, Middle East, Africa
North America
bioMérieux Demonstrates Emerging Technologies that Impact Speed of Diagnostics for Infectious Disease Clinicians
20 October, 2011
bioMerieux shares new diagnostic tools at the 49th Annual Meeting of the Infectious Diseases Society of America - visit IDSA booth #916
bioMérieux - First-Half Results at June 30, 2011
06 September, 2011
The Board of Directors of bioMerieux, a world leader in the field of in vitro diagnostics, met today to approve the consolidated financial statements for the six months ended June 30, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who had performed a limited review of the financial statements.
Completion of the AES Chemunex Group Acquisition and Filing of a Tender Offer for the AES Chemunex Shares
22 July, 2011
bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group.
bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients
19 July, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. This acquisition is bioMérieux’s tenth in the last five years.
bioMérieux - First-Half 2011 Business Review
19 July, 2011
bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.
bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety
22 June, 2011
VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing
IAFP Names bioMérieux, Inc. as Recipient of the Prestigious Black Pearl Award
31 May, 2011
The International Association for Food Protection (IAFP) selected bioMerieux, Inc., as the 2011 recipient of the prestigious Black Pearl Award. Sponsored by Wilbur Feagan and F & H Food Equipment Company, the Black Pearl Award will be presented at IAFP's Annual Meeting in Milwaukee, Wisconsin in August.
bioMérieux Gains International Approval for its Automated Solution: VIDAS® Easy Salmonella
26 May, 2011
AOAC Official Methods(SM) Approval Underscores VIDAS® Excellence in Food Safety Testing
U.S. FDA Recommends bioMérieux's VIDAS® Staphylococcal Enterotoxin Assay (SET2) as Primary Screening Method for Food Safety Testing
26 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, announced today that the VIDAS® Staphylococcal enterotoxins assay (SET2) has been included in the United States Food and Drug Administration’s (FDA) Bacteriological Analytical Manual (BAM) for food safety testing. The FDA’s BAM is recommending that the VIDAS SET2 protocol be used as the primary screening method for the presence of Staphylococcal enterotoxins in suspect food samples and culture isolates.